{
  "title": "Paper_642",
  "abstract": "pmc J Nat Prod J Nat Prod 822 acssd np Journal of Natural Products 0163-3864 1520-6025 pubs.acs.org/jnp pmc-is-collection-domain yes pmc-collection-title ACS AuthorChoice PMC12481565 PMC12481565.1 12481565 12481565 40851498 10.1021/acs.jnatprod.5c00786 1 Article Identification\nof Cembrane Diterpenoids from Sinularia 6866192 https://orcid.org/0000-0002-9409-7645 Orfanoudaki Maria 7724962 Shaikh Anam F. 3311486 https://orcid.org/0000-0002-7824-2507 Wang Dongdong 7724952 Singh Vivek 1511300 https://orcid.org/0000-0001-8751-4482 Du Lin 1202881 Wilson Jennifer A. 6334075 Wamiru Antony 6334078 Goncharova Ekaterina I. 7724944 Pruett Nathanael 7724923 Hoang Chuong D. 3005753 https://orcid.org/0000-0001-8988-1964 Wilson Brice A. P. 840770 https://orcid.org/0000-0003-0772-4856 O’Keefe Barry R.  † Molecular\nTargets Program 272101 Center for Cancer Research,\nNational Cancer Institute Frederick Maryland 21702-1201 United States  ‡ Thoracic\nSurgery Branch, National Cancer Institute National Institutes of Health Bethesda Maryland 20892 United States  § Advanced\nBiomedical Computational Science Frederick\nNational Laboratory for Cancer Research Frederick Maryland 21702-1201 United States  ∥ Natural\nProducts Branch, Developmental Therapeutics Program, Division of Cancer\nTreatment and Diagnosis National Cancer\nInstitute Frederick Maryland 21702-1201 United States * brice.wilson@nih.gov * chuong.hoang@nih.gov * okeefeba@mail.nih.gov 25 8 2025 26 9 2025 88 9 497980 2193 2203 2448109 25 6 2025 14 8 2025 08 8 2025 25 8 2025 30 09 2025 01 10 2025 01 10 2025 Not subject to U.S. Copyright. Published 2025 by American Chemical Society and American Society of Pharmacognosy 2025 U.S. Government https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under CC-BY-NC-ND 4.0 Diffuse pleural mesothelioma (DPM) is a rare but aggressive\nlate-onset\ncancer. A high-throughput screen of a natural product fraction library\nidentified fractions derived from an aqueous extract of Sinularia 1 4 7 11 2 3 8 9 Center for Cancer Research 10.13039/100031022 75N91019D00024 Center for Cancer Research 10.13039/100031022 HHSN261200800001E Center for Cancer Research 10.13039/100031022 ZIA BC 011471 Center for Cancer Research 10.13039/100031022 ZIA BC 011657 Center for Cancer Research 10.13039/100031022 ZIA BC 011904 pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes document-id-old-9 np5c00786 document-id-new-14 np5c00786 production-flag-MathML-config-version 3 production-flag-journal-citation-display-style acs-no-titles production-flag-journal-date-display-style dates-used-rcd-rvd-acc production-flag-si-avail yes document-id-alt-64 ec3fab268b306f0db36c788f4097f19022c102d555bdab61cb952c803a4d4525 Soft corals (on the order of\nAlcyonacea) are sessile benthic organisms. Anatomically, the majority\nof the organism is comprised of soft tissue, a proteinaceous hydroskeleton\nwith embedded calcareous support structures (sclerites).  Sinularia   Sinularia Sarcophyton Eunicea Clavularia Nephthea Lobophytum  ε   Diffuse pleural mesothelioma (DPM)\nis a rare aggressive malignancy\naffecting the mesothelial cells in the pleural lining surrounding\nthe lungs often related to asbestos exposure.     In a recent DPM oriented high-throughput screening campaign using\na fractionated natural product library, fractions from an extract\nof Sinularia 1 4 7 11 5 6 12 13 Results and Discussion Despite the need for treatment\noptions for DPM, few large-scale\nhigh-throughput drug discovery campaigns have been published directly\nassessing the effect of small molecules on the growth of mesothelioma\ncell lines. Figure 1 Primary\nscreening outcomes. (A) Violin plot showing the distribution\nof all marine primary screening fractions and mesothelioma cell line-specific\nactivity. (B) The behavior of all NPNPD fractions derived from the Sinularia The resulting pure natural products were tested\nfor DPM specificity\nby counter-screening against a patient-derived normal pleura mesothelial\ncell line, NP1. Figure S1 Figure S1 Data analysis following primary screening\nof ∼34,000 marine\nfractions against the two DPM cell lines revealed that most samples\ndid not significantly reduce viability in either cell line, resulting\nin a median reading of 81% viability ( Figure Figure Sinularia Figure Sinularia 1 4 7 11 5 6 12 13 Sinulariolone\nB ( 1 20 30 7 2 + m z 20 29 6 + + m z 20 30 7 + –1 1 1 d 6 Table 3 2 3 13 Table 3 C C 2 C 1 5 2 5 1 H/C H H C H C Figure 1 Figure H H 3 H 3 3 H 3 H H 3 H 3 3 H 3 3 H H H H ε Figure 1 R S R S R R R 5 2 (A) Key COSY, HMBC, and\nNOESY correlations of 1 δ  S δ  R S R 1a 1b 1 1 1  1 13 1 4 d 6   1  2  3  4 No. δ C δ H J δ C δ H J δ C δ H J δ C δ H J 1 32.1, CH 3.06, td (11.4, 5.8) 32.3, CH 2.95,\ntd (11.2, 6.0) 32.4, CH 2.98, m 32.1, CH 2.86, td (11.2, 6.0) 2 38.2, CH 2 1.55, m, Ha 38.0, CH 2 1.54, td (11.2, 2.6), Ha 38.2, CH 2 1.54, m, Ha 38.1, CH 2 1.58, m, Ha 1.76, m, Hb 1.76, m, Hb 1.77, m, Hb 1.70, t (12.4), Hb 3 73.0, CH 3.32, m 72.9,\nCH 3.29, m 73.1, CH 3.31,\nm 72.7, CH 3.35, m 4 87.1, C  87.0, C  87.2, C  86.9, C  5 37.3, CH 2 1.55, m, Ha 37.2, CH 2 1.63, m 37.4, CH 2 1.60, m, Ha 36.9, CH 2 1.59, m 1.66, m, Hb 1.66, m, Hb 6 24.9, CH 2 1.80, m 25.2, CH 2 1.72, m, Ha 24.9, CH 2 1.76, m, Ha 24.9, CH 2 1.57, m 1.81,\nm, Hb 1.82, m, Hb 7 78.5, CH 4.11, dd (7.8, 6.4) 78.5,\nCH 4.01, t (7.4) 78.5, CH 4.03, t (7.8) 81.3, CH 4.49, dd (7.6,\n5.8) 8 74.8, C  75.1, C  75.0, C  57.8, C  9 70.5, CH 3.87, m 80.4, CH 3.50, dd (7.6, 3.2) 80.3,\nCH 3.60, m 28.8,\nCH 2 1.83, m, Ha 2.39, ddd (14.0, 8.4, 3.0), Hb 10 43.1, CH 2 2.68, m, Ha 40.4, CH 2 2.77, dd (20.8, 3.4), Ha 41.1, CH 2 2.75, dd (20.4, 3.2), Ha 33.7, CH 2 2.57, ddd (20.8, 8.4,\n3.0), Ha 3.84, m, Hb 3.81,\ndd (20.8, 7.6), Hb 3.84, dd (20.4, 8.6), Hb 3.31, m, Hb 11 210.4, C  210.8, C  210.9,\nC  210.4, C  12 91.2, C  91.2, C  91.3, C  90.7, C  13 33.9, CH 2 1.81, m, Ha 33.9, CH 2 1.81, m, Ha 34.1, CH 2 1.82, m, Ha 33.8, CH 2 1.86, m, Ha 2.17,\ndd (14.8, 5.2), Hb 2.18, dd (15.0, 5.8), Hb 2.18, dd (15.0, 5.0), Hb 2.27, dd (15.2, 6.2), Hb 14 30.2,\nCH 2 1.05, td (11.4, 5.8), Ha 30.2, CH 2 1.05, td (11.2, 4.4),\nHa 30.3, CH 2 1.04,\nm, Ha 30.2, CH 2 1.06, m, Ha 1.87, m, Hb 1.91,\nm, Hb 1.91, m, Hb 1.97, m, Hb 15 145.0, C  144.9, C  145.0, C  145.1, C  16 167.7, C  167.6, C  167.8, C  167.6, C  17 124.2, CH 2 5.53, s, Ha 124.4, CH 2 5.53, s, Ha 124.5, CH 2 5.53, s, Ha 124.2, CH 2 5.52, s, Ha 6.14, s, Hb 6.14, s, Hb 6.14, s, Hb 6.11, s, Hb 18 17.2, CH 3 0.95, s 17.3,\nCH 3 0.95, s 17.5, CH 3 0.95, s 17.0, CH 3 0.93, s 19 20.2, CH 3 0.92, s 20.6, CH 3 0.92, s 20.6, CH 3 0.93,\ns 20.4, CH 3 1.02, s 20 28.9, CH 3 1.34,\ns 28.7, CH 3 1.38, s 28.9, CH 3 1.37, s 29.0,\nCH 3 1.34, s 1′   57.7, CH 3 3.28, s 65.4, CH 2 3.39, m 168.9, C  3.57, m 2′     15.5, CH 3 1.09, t (6.8) 23.5, CH 3 1.77, s 3-OH  4.83, d (5.4)  4.85, d (5.2)  4.83, d\n(4.8)  4.84, d (5.4) 8-OH/NH  4.35, s  4.36, s  4.19, s  7.52, s 9-OH  4.64, d (3.6)       a Spectrum recorded on 125 MHz. b Spectrum recorded on 600 MHz. The absolute configuration of compound 1 Figures 1 R S S R 1a 1b Figure H δ  S δ  R S Figure 1 R S R S R R R. 1 Figure R S R S R R R 1 Δε Δε Δε Figure 1 Figure Table S7 Sinulariolones C–E ( 2 4 1 5 Table 21 32 7 2 22 34 7 3 22 33 6 4 2 1 Table 3 H/C C 2 C 1 1 2 3 Figure S2 2 3 2 H/C 3 H/C 1 2 3 2 C Figure S2 Table 4 5 δ  N H‑8 C‑1′ H‑2′/C‑2′  5 C C C C 3 C 5 C 4 Figure S2 Lobophytum Sinularia N  2 4 R* S* R* S* R* R* R* 2 3 R* S* R* S* R* R* 4 1 5 Figure S2 1 4 Figure S3A R S R S R R R 1 4 Figure 3 Experimental (blue line) and calculated (red line) ECD\nspectra\nof 4 7 8 10 The HRESIMS spectrum of sinulariolone F ( 7 m z 2 + + 20 28 7 Table Figure 7 1 H/C H/C C H 3 H Figure 1 7 Figures 1 7 R* S* R* S* S* R H H 3 H R* S* 7 Figure 7 R S R S S R S R 7 Figure 7. 4 Key\nCOSY, HMBC, and NOESY correlations of 7 8 10 2  1 13 δ J 7 11 d 6   7  8  9  1  1 No. δ C δ H J δ C δ H J δ C δ H J δ C δ H J δ C δ H J 1 31.5, CH 2.54, m 32.5, CH 3.17, m 32.8, CH 3.08, m 35.3, CH  35.5, CH 2.99, m 2 37.5, CH 2 1.64, m 38.6,\nCH 2 1.35, t (12.4), Ha 38.6, CH 2 1.34, m, Ha 32.8, CH 2 2.98, m 32.8, CH 2 1.24, m, Ha 1.93, m, Hb 1.93, m, Ha 1.19, m, Ha 2.09, m, Hb 3 71.5, CH 3.41, m 70.7, CH 3.14, m 70.6, CH 3.13, m 60.1, CH 1.98, m, Hb 59.2, CH 3.18, dd (10.4, 3.8) 4 86.0, C  86.0, C  85.9, C  60.0, C 3.03, m 59.7, C  5 37.4, CH 2 1.56, m, Ha, 37.1, CH 2 1.52, m, Ha 37.3, CH 2 1.55, m, Ha 34.8,\nCH 2 1.04, m, Ha 33.7, CH 2 0.83, m, Ha 1.95, ddd (12.8, 9.4, 3.4), Hb 2.11, m, Hb 2.14, m, Hb 1.95, m, Hb 1.94, m,\nHb 6 26.7, CH 2 1.65, m, Ha 27.8, CH 2 1.55, m, Ha 27.1, CH 2 1.57, m, Ha 29.0, CH 2 1.42, m, Ha 26.9, CH 2 1.66, m, Ha 1.82, m, Hb 1.80, m, Hb 1.82, m, Hb 1.59, dd (14.6, 10.6), Hb 1.75, m, Hb 7 83.4, CH 3.85, dd (9.4, 5.0) 87.7, CH 3.79,\ndd (10.8, 7.4) 88.4, CH 3.74, dd (10.8,\n3.4) 77.2, CH 3.37 m 76.5,\nCH 5.03, d (9.0) 8 71.4, C  73.8, C  56.2, C  85.0, C  82.7, C  9 65.6, CH 3.44, d (4.2) 150.7, CH 6.84, d (15.2) 151.9, CH 6.87,\nd (15.2) 75.4, CH 4.03, td (8.4, 4.0) 75.3, CH 4.85, t (8.8) 10 55.2, CH 4.10, d (4.2) 126.7, CH 7.20, d (15.2) 126.8,\nCH 7.16, d (15.2) 35.1, CH 2 1.89, m, Ha 32.1, CH 2 2.06, m, Ha 2.07, m, Hb 2.30, m, Hb 11 208.7, C  202.4, C  202.3, C  79.0, CH 4.15, dd (9.4, 5.2) 79.7,\nCH 4.34, dd (9.6, 5.4) 12 89.4, C  90.3, C  90.4, C  88.0, C  87.4, C  13 32.0, CH 2 2.14, m, Ha 34.8, CH 2 1.88, m, Ha 34.7, CH 2 1.89, m, Ha 29.2,\nCH 2 1.70, m, Ha 29.0, CH 2 1.78, m, Ha 2.75, dd (15.6, 6.2), Hb 2.09, m, Hb 2.09, m, Hb 2.13, dd (16.4, 5.0), Hb 2.16, dd (16.6, 5.6), Hb 14 30.0, CH 2 1.14, td (12.8,\n6.4), Ha 29.7, CH 2 1.04, m, Ha 29.6, CH 2 1.04, m, Ha 32.4, CH 2 1.18, m, Ha 32.4, CH 2 1.34 m, Ha 2.24, m,\nHb 1.80, m, Hb 1.84, m, Hb 2.35, m, Hb 2.35, m, Hb 15 144.3, C  145.6, C  145.3, C  145.4, C  145.0, C  16 167.0, C  167.8, C  167.8, C  168.6,\nC  168.4, C  17 124.8, CH 2 5.56, s, Ha 123.9,\nCH 2 5.46, s, Ha 124.0, CH 2 5.47, s, Ha 123.0, CH 2 5.45, s, Ha 123.6, CH 2 5.51, s, Ha 6.08, s, Hb 6.09, s, Hb 6.09, s, Hb 6.04, s, Hb 6.09, s, Hb 18 18.3, CH 3 0.96, s 20.0, CH 3 1.05, s 20.1, CH 3 1.05, s 16.2,\nCH 3 1.09, s 15.9, CH 3 1.12, s 19 25.2, CH 3 1.23, s 24.5, CH 3 1.14, s 24.1, CH 3 1.08, s 11.0, CH 3 0.97,\ns 12.5, CH 3 1.19, s 20 27.8, CH 3 1.56,\ns 28.0, CH 3 1.43, s 28.1, CH 3 1.43, s 28.9,\nCH 3 1.11, s 28.5, CH 3 1.13, s 1′         170.7,\nC  2′         20.6, CH 3 1.95, s 3′         169.5,\nC  4′         20.5, CH 3 2.04, s 3-OH  4.85, d (5.4)  4.76, br\ns       7-OH        4.79, d (5.2)   8-OH  5.50, s  5.17, s  8.38, br s     9-OH        4.49, d (3.6)   a Spectrum recorded on 125 MHz. b Spectrum recorded on 600 MHz. c Spectrum recorded on 500 MHz. Both sinulariolones G ( 8 9 20 28 6 8 20 29 5 9 8 Table 5 trans H J C H J C C C H Figure 9 2 H 8 C 8 C 9 3 H C C Figure S4 8 9 1 Figures S4 R S R S R E R 8 Figures S3 Sinulariolone\nI ( 10 20 30 6 m z + 20 31 6 + 1 10 d 6 3 2 3 13 3 C C 2 C 10 12 12 10 H 12 10 H H 2 H 2 H H 2 H H 3 H C C Figure 10 Figure H 3 H 3 H 3 3 3 H H H H H H H 3 H 3 ε Figure 10 R* S* S* S* S* R* S* R* 10 R S S S S R S R 10 Figure 10 Sinulariolone J ( 11 24 34 8 Table 11 10 C 3 H C C 3 H C 11 H H Figure S4 11 10 Figures S3 and S4 11 R S S S S R S R Four previously reported cembrane diterpenoids, sinulariolone ( 5 6 12 13 Table S9 Figure S5 Following bioassay-guided isolation of compounds 1 13 2 3 8 9 Table Table Figures S6–S9 50 3 LD 50 2 3 8 9 Compound MB24 (μM) MB52 (μM) NP1 (μM)  2 11.4 4.7 5.2  3 13.3 7.1 7.8  8 14.2 7.9 15.7  9 27.4 12.5 15.9 The outcomes of this study have identified nine new\ncembrane diterpenoids,\nnamely, sinulariolones B–J ( 1 4 7 11 5 6 12 13 Experimental Section General Experimental Procedures Optical rotations were\nmeasured on a Rudolph research analytical AUTOPOL IV automatic polarimeter\nusing a cell of 0.25 dm path length at 25 °C, and UV spectra\nwere measured with an HP 8453 UV–vis spectrophotometer. ECD\nexperiments were performed on a J-1500 CD spectrophotometer, and IR\nspectra were recorded with a Bruker ALPHA II FT-IR spectrometer. NMR\nspectra were obtained with: (a) a Bruker Avance III NMR spectrometer\nequipped with a 3 mm CP TCI probe operating at a frequency of 600\nMHz for the 1 13 1 1 1 13 1 13 1 13 1 1 1 13 1 1 1 13 H C d 6 H C 3 H C 3 Collection, Extraction, and Isolation The soft coral Sinularia 2 C21254 C21255 C21254 A portion of the Sinularia C21254 4 8 18 10 8 1 9 8 7 18 4 Fraction 5 from the initial C 4 5 8 18 3 18 8 6 8 11 12 Fraction\n6 from the initial C 4 8 4 8 2 4 13 Sinulariolone B ( 1 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 d 6 Table m z 2 + 20 29 6 + m z + 20 30 7 + Preparation of MTPA Esters of Compound 1a To a solution of 1 R 2 18 S 1 1a R S 1b ( S 1 1a White amorphous powder; 1 13 Table S10 m z + 30 35 3 8 + ( R 1 1b White amorphous powder; 1 13 Table S10 m z + 30 35 3 8 + Sinulariolone C ( 2 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 Table m z 2 + 21 31 6 + m z + 21 32 7 + Sinulariolone D ( 3 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 Table m z 2 + 22 33 6 + m z + 22 34 7 + Sinulariolone E ( 4 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 Table m z + 22 34 6 + Sinulariolone F ( 7 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 d 6 Table 1 3 Table S8 m z 2 + 20 27 6 + m z + 20 28 7 + Sinulariolone G ( 8 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 d 6 Table 1 3 Table S8 m z 2 + 20 27 5 + m z + 20 28 6 + Sinulariolone H ( 9 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 d  6 Table 1 3 Table S8 m z + 20 30 5 + Sinulariolone I ( 10 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 Table m z 2 + 20 29 5 + m z + 20 31 6 + Sinulariolone J ( 11 White amorphous powder;\n[α] D 23 546 633 c max ε Δε –1 1 13 d 6 Table 1 3 Table S8 m z + 24 34 8 + 3 + 22 31 6 + Single-Crystal X-ray Structure Determination of Sinulariolone\nB ( 1 A suitable colorless crystal of sinulariolone\nB ( 1 20 32 8 1 k k a b c V 3 Z d calc 3 Rotation frames were integrated\nusing CrysAlisPro, producing a list of unaveraged F 2 F 2 h k l R int F 2 w 2 F o 2 P 2 P P F o 2 F c 2 R wR F R wR 3 1 2448109 https://www.ccdc.cam.ac.uk/structures/ Computational Methods 3D structures of the molecules\nwere drawn and subjected to conformational analysis using MMFF94 as\na force field and the GMMX methodology. Geometrical optimization and\nenergy calculation of conformers occurring in an energy window (Δ ε Tables S1–S6 1 4 11 7 8 13 10 High-Throughput Screening Campaign Two patient-derived\ncell lines, MB24 (sarcomatoid) and MB52 (epithelial), were obtained\nfrom MesoBank, U.K. (N.P.), % Viability = 100 * ( Value Substance − Value LowControl ) ( Value HighControl − Value LowControl ) Assay actives, “hits”,\nwere then identified using our previously published source fraction\npool (SFP) methodology. Dose–Response LD 50 Compounds 1 13 2 3 8 9 50 2 3 8 9 50 Supplementary Material This work was supported by the Intramural\nResearch\nProgram of the Center for Cancer Research of the National Cancer Institute,\nNational Institutes of Health, under contracts HHSN261200800001E and\n75N91019D00024 with project numbers ZIA BC 011471 (B.R.O.), ZIA BC\n011657 (C.D.H), and ZIA BC 011904 (B.A.P.W.). The authors thank Dr.\nMichael Gau (Department of Chemistry, University of Pennsylvania)\nfor performing the X-ray analysis. This research utilized the computational\nresources of the NIH HPC Biowulf cluster and was funded in part by\nthe Intramural Research Program of the NIH, National Cancer Institute,\nCenter for Cancer Research. The authors also thank Dr. Sergey G. Tarasov\nand Ms. Marzena Dyba of the Biophysics Resource in the Center for\nStructural Biology, NCI-Frederick, for technical support and help\nwith the ECD measurements. The NMR data\nfor the following compounds have been deposited in the Natural Products\nMagnetic Resonance Database (NP-MRD; www.np-mrd.org S R The\nSupporting Information is\navailable free of charge at https://pubs.acs.org/doi/10.1021/acs.jnatprod.5c00786 NMR, HRESIMS, ECD, and IR spectra of 1–4 7–11 5 6 12 13 1 4 7 8 10 13 50 2 3 8 9 PDF This research was\nsupported by the Intramural Research Program of the National Institutes\nof Health (NIH). The contributions of the NIH author(s) were made\nas part of their official duties as NIH federal employees, are in\ncompliance with agency policy requirements, and are considered Works\nof the United States Government. However, the findings and conclusions\npresented in this paper are those of the author(s) and do not necessarily\nreflect the views of the NIH or the U.S. Department of Health and\nHuman Services. The authors declare no\ncompeting financial interest. Larkin M. F. Davis T. R. Harasti D. Cadiou G. Poulos D. E. Smith S. D. A. The rapid decline of an Endangered temperate soft coral\nspecies Estuar. Coast. Shelf Sci. 2021 255 107364 10.1016/j.ecss.2021.107364 Rahman M. A. Oomori T. Wörheide G. Calcite Formation\nin Soft Coral Sclerites\nIs Determined by a Single Reactive Extracellular Protein J. Biol. Chem. 2011 286 36 31638 31649 10.1074/jbc.M109.070185 21768106 PMC3173117  Sinularia World\nRegister of Marine Species https://www.marinespecies.org/aphia.php?p=taxdetails&id=205854 Cantin N. Gilmour J. Coral bleaching\nevents Australian Institute of Marine Science https://www.aims.gov.au/research-topics/environmental-issues/coral-bleaching/coral-bleaching-events Yan X. Liu J. Leng X. Ouyang H. Chemical Diversity and Biological\nActivity of Secondary Metabolites from Soft Coral Genus Sinularia Mar. Drugs 2021 19 6 335 10.3390/md19060335 34208171 PMC8230912 Panithanarak T. Effects of\nthe 2010 coral bleaching on phylogenetic clades and diversity of zooxanthellae\n( Symbiodinium Sinularia Plankton and Benthos Research 2015 10 11 17 10.3800/pbr.10.11 Ermolenko E. V. Imbs A. B. Gloriozova T. A. Poroikov V. V. Sikorskaya T. V. Dembitsky V. M. Chemical\nDiversity of Soft Coral Steroids and Their\nPharmacological Activities Mar. Drugs 2020 18 12 613 10.3390/md18120613 33276570 PMC7761492 Savić M. P. Sakač M. N. Kuzminac I. Z. Ajduković J. J. Structural\ndiversity of bioactive steroid compounds isolated from soft corals\nin the period 2015–2020 J.Steroid Biochem.\nMol. Biol. 2022 218 106061 10.1016/j.jsbmb.2022.106061 35031429 Nurrachma M. Y. Sakaraga D. Nugraha A. Y. Rahmawati S. I. Bayu A. Sukmarini L. Atikana A. Prasetyoputri A. Izzati F. Warsito M. F. Cembranoids of Soft\nCorals: Recent Updates and Their Biological Activities Nat. Prod. Bioprospect. 2021 11 3 243 306 10.1007/s13659-021-00303-2 33890249 PMC8141092 Zhang N. Xu W. Yan Y. Chen M. Li H. Chen L. Cembrane diterpenoids:\nChemistry and pharmacological activities Phytochemistry 2023 212 113703 10.1016/j.phytochem.2023.113703 37164145 Li Y. Peng L. Zhang T. Progress of\nStudies on the Natural\nCembranoids from the Soft Coral Species of Sarcophyton Med. Chem. Bioact. Nat. Prod. 2005 257 300 10.1002/0471739340.ch6 Scesa P. D. Lin Z. Schmidt E. W. Ancient\ndefensive terpene biosynthetic gene clusters\nin the soft corals Nat. Chem. Biol. 2022 18 6 659 663 10.1038/s41589-022-01027-1 35606556 PMC10262820 Janes S. M. Alrifai D. Fennell D. A. Perspectives on the Treatment of\nMalignant Pleural Mesothelioma N Engl J. Med. 2021 385 13 1207 1218 10.1056/NEJMra1912719 34551230 Rozitis E. Johnson B. Cheng Y. Y. Lee K. The use of immunohistochemistry,\nfluorescence in situ hybridization, and emerging epigenetic markers\nin the diagnosis of malignant pleural mesothelioma (MPM): a review Front. Oncol. 2020 10 1742 10.3389/fonc.2020.01742 33014860 PMC7509088 Gounant V. Brosseau S. Zalcman G. Immunotherapy, the promise for present\nand future of malignant pleural mesothelioma (MPM) treatment Ther. Adv. Med. Oncol. 2021 10.1177/17588359211061956 PMC8669877 34917175 Oddone E. Bollon J. Nava C. R. Bugani M. Consonni D. Marinaccio A. Magnani C. Barone-Adesi F. Predictions\nof Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos\nUse Int. J. Environ. Res. Public Health 2020 17 2 607 10.3390/ijerph17020607 31963601 PMC7013387 Alice B. Beatrice A. Franco S. Surgical\nManagement\nof Malignant Pleural Mesothelioma: From the Past to the Future Mesothelioma Ilze S. IntechOpen 2022 Gupta A. Yadav K. Yadav A. Ahmad R. Srivastava A. Kumar D. Khan M. A. Dwivedi U. N. Mannose-specific\nplant and microbial lectins as antiviral agents: A review Glycoconj. J. 2024 41 1 1 33 10.1007/s10719-023-10142-7 38244136 Nicolini F. Bocchini M. Bronte G. Delmonte A. Guidoboni M. Crinò L. Mazza M. Malignant pleural mesothelioma: state-of-the-art\non current therapies and promises for the future Front. Oncol. 2020 9 1519 10.3389/fonc.2019.01519 32039010 PMC6992646 Bertin B. Zugman M. Schvartsman G. The Current\nTreatment Landscape of\nMalignant Pleural Mesothelioma and Future Directions Cancers 2023 15 24 5808 10.3390/cancers15245808 38136353 PMC10741667 Baas P. Scherpereel A. Nowak A. K. Fujimoto N. Peters S. Tsao A. S. Mansfield A. S. Popat S. Jahan T. Antonia S. First-line nivolumab plus ipilimumab in unresectable\nmalignant pleural mesothelioma (CheckMate 743): a multicentre, randomised,\nopen-label, phase 3 trial Lancet 2021 397 10272 375 386 10.1016/S0140-6736(20)32714-8 33485464 Vogelzang N. J. Rusthoven J. J. Symanowski J. Denham C. Kaukel E. Ruffie P. Gatzemeier U. Boyer M. Emri S. Manegold C. Phase III study of pemetrexed in combination\nwith cisplatin versus cisplatin alone in patients with malignant pleural\nmesothelioma J. Clin. Oncol. 2003 21 14 2636 2644 10.1200/JCO.2003.11.136 12860938 Dell’Anno I. Melani A. Martin S. A. Barbarino M. Silvestri R. Cipollini M. Giordano A. Mutti L. Nicolini A. Luzzi L. A Drug Screening Revealed\nNovel Potential Agents against Malignant Pleural Mesothelioma Cancers (Basel) 2022 14 10 2527 10.3390/cancers14102527 35626133 PMC9139775 Chmielewska-Kassassir M. Wozniak L. A. Phytochemicals in Malignant Pleural Mesothelioma TreatmentReview\non the Current Trends of Therapies Int. J.\nMol. Sci. 2021 22 15 8279 10.3390/ijms22158279 34361048 PMC8348618 Thornburg C. C. Britt J. R. Evans J. R. Akee R. K. Whitt J. A. Trinh S. K. Harris M. J. Thompson J. R. Ewing T. L. Shipley S. M. NCI Program for Natural Product Discovery:\nA Publicly-Accessible Library of Natural Product Fractions for High-Throughput\nScreening ACS Chem. Biol. 2018 13 9 2484 2497 10.1021/acschembio.8b00389 29812901 PMC8130845 Pruett N. Singh A. Shankar A. Schrump D. S. Hoang C. D. Normal\nmesothelial cell lines newly derived from human pleural biopsy explants Am. J. Physiol. Lung Cell Mol. Physiol. 2020 319 4 L652 l660 10.1152/ajplung.00141.2020 32726133 PMC7642897 Guerrero P. P. Read R. W. Batley M. Janairo G. C. The Structure of\na Novel Cembranoid Diterpene from a Philippine Collection of the Soft\nCoral Sinularia flexibilis J. Nat. Prod. 1995 58 8 1185 1191 10.1021/np50122a005 Ohtani I. Kusumi T. Kashman Y. Kakisawa H. High-field FT NMR application\nof Mosher’s method. The absolute configurations of marine terpenoids J. Am. Chem. Soc. 1991 113 11 4092 4096 10.1021/ja00011a006 Wang D. Murtaza M. Wood S. A. Mellick G. D. Miao W. G. Guymer G. P. Forster P. I. Feng Y. Quinn R. J. A Grand\nChallenge. 3. Unbiased Phenotypic Function of Metabolites from Australia\nPlants Gloriosa superba Alangium villosum J. Nat.\nProd. 2020 83 5 1440 1452 10.1021/acs.jnatprod.9b00880 32372642 Pretsch E. Bühlmann P. Badertscher M. Introduction Structure Determination of Organic Compounds: Tables\nof Spectral Data Springer 2020 1 3 10.1007/978-3-662-62439-5_1 Rashid M. A. Gustafson K. R. Boyd M. R. HIV-Inhibitory Cembrane Derivatives\nfrom a Philippines Collection of the Soft Coral Lobophytum Species J. Nat. Prod. 2000 63 4 531 533 10.1021/np990372p 10785433 Iguchi K. Nishimura K. Yamazaki K. Iwashima M. Yamada Y. New Cembranolide\nDiterpenes with a Dimethylamino Group from the Okinawan Soft Coral\n(Sinularia sp.) Chem. Lett. 1992 21 1 127 130 10.1246/cl.1992.127 Mori K. Suzuki S. Iguchi K. Yamada Y. 8,11-epoxy bridged\ncembranolide diterpene from the soft coral Sinularia flexibilis Chem. Lett. 1983 12 10 1515 1516 10.1246/cl.1983.1515 Ma A. Deng Z. van Ofwegen L. Bayer M. Proksch P. Lin W. Dendronpholides A-R,\nCembranoid Diterpenes from the Chinese Soft\nCoral Dendronephthya J.\nNat. Prod. 2008 71 7 1152 1160 10.1021/np800003w 18563933 Hmeljak J. Sanchez-Vega F. Hoadley K. A. Shih J. Stewart C. Heiman D. Tarpey P. Danilova L. Drill E. Gibb E. A. Integrative Molecular Characterization of Malignant\nPleural Mesothelioma Cancer Discov. 2018 8 12 1548 1565 10.1158/2159-8290.CD-18-0804 30322867 PMC6310008 McCloud T. G. High Throughput\nExtraction of Plant, Marine and Fungal Specimens for Preservation\nof Biologically Active Molecules Molecules 2010 15 7 4526 4563 10.3390/molecules15074526 20657375 PMC6257593 Sheldrick G. M. SHELXT\n- integrated space-group and crystal-structure determination Acta Crystallogr. A Found Adv. 2015 71 1 3 8 10.1107/S2053273314026370 25537383 PMC4283466 Dolomanov O. V. Bourhis L. J. Gildea R. J. Howard J. A. K. Puschmann H. OLEX2: a complete\nstructure solution, refinement and analysis program J. Appl. Crystallogr. 2009 42 2 339 341 10.1107/S0021889808042726 Biowulf: High Performance Computing at the\nNIH NIH https://hpc.nih.gov/systems/ Rintoul R. C. Rassl D. M. Gittins J. Marciniak S. J. MesobanK\nUK: an international mesothelioma bioresource Thorax 2016 71 4 380 382 10.1136/thoraxjnl-2015-207496 26467803 PMC4819625 Pruett N. Singh A. Shankar A. Schrump D. S. Hoang C. D. Normal\nmesothelial cell lines newly derived from human pleural biopsy explants Am. J. Physiol. Lung Cell. Mol. Physiol. 2020 319 4 L652 L660 10.1152/ajplung.00141.2020 32726133 PMC7642897 Scudiero D. A. Shoemaker R. H. Paull K. D. Monks A. Tierney S. Nofziger T. H. Currens M. J. Seniff D. Boyd M. R. Evaluation\nof a soluble tetrazolium/formazan assay for cell growth and drug sensitivity\nin culture using human and other tumor cell lines Cancer Res. 1988 48 17 4827 4833 3409223 Wilson B. A. P. Li N. Martinez Fiesco J. A. Dalilian M. Wang D. Smith E. A. Wamiru A. Shah R. Goncharova E. I. Beutler J. A. Biochemical Discovery, Intracellular Evaluation,\nand Crystallographic Characterization of Synthetic and Natural Product\nAdenosine 3′,5′-Cyclic Monophosphate-Dependent Protein\nKinase A (PKA) Inhibitors ACS Pharmacol. Transl.\nSci. 2023 6 4 633 650 10.1021/acsptsci.3c00010 37082750 PMC10111623 ",
  "metadata": {
    "Title of this paper": "Biochemical Discovery, Intracellular Evaluation,\nand Crystallographic Characterization of Synthetic and Natural Product\nAdenosine 3′,5′-Cyclic Monophosphate-Dependent Protein\nKinase A (PKA) Inhibitors",
    "Journal it was published in:": "Journal of Natural Products",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12481565/"
  }
}